AzTrials
AzTrials

Periodontal DiseasesNCT07530978

ORAL HYGIENE, PERIODONTAL STATUS AND QUALITY OF LIFE

An observational study of Periodontal Diseases and Gingivitis, run by Abant Izzet Baysal University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This cross-sectional study aims to evaluate the relationship between oral hygiene habits, periodontal status, and oral health-related quality of life in adult individuals. A total of approximately 160 participants attending the Department of Periodontology will be included. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Periodontal Diseases, Gingivitis, Periodontitis
What is being tested?
Oral Health Assessment and OSHIP-Perio Questionnaire
Type of treatment
Pill or oral medicine
How many people
463 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Oct 2025to 15 Jun 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: The study population will consist of individuals aged 18 years and older presenting to the Department of Periodontology at Bolu Abant İzzet Baysal University Faculty of Dentistry. Participants will be classified into periodontally healthy, gingivitis, and periodontitis groups according to the 2017 classification of periodontal diseases and conditions.

Who may be able to join

  • Individuals aged 18 years and older
  • Patients presenting to the Department of Periodontology Individuals willing to participate and provide informed consent

Who cannot join

  • Use of antibiotics or anti-inflammatory drugs within the last 3 months
  • History of periodontal treatment within the last 6 months
  • Pregnancy or lactation
  • Individuals unable to complete the questionnaire

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Faculty of Dentistry, Bolu Abant İzzet Baysal University, Department of Periodontics

    Bolu, Bolu, 14100

Other trials in Turkey (Türkiye)

About this study

Official title: EVALUATION OF THE EFFECT OF INDIVIDUALS' ORAL HYGIENE HABITS AND PERIODONTAL STATUS ON QUALITY OF LIFE

This cross-sectional study aims to evaluate the relationship between oral hygiene habits, periodontal status, and oral health-related quality of life in adult individuals. A total of approximately 160 participants attending the Department of Periodontology will be included. Periodontal status will be assessed using standard clinical parameters, including probing depth, clinical attachment loss, bleeding on probing, and plaque index. In addition, the Periodontal Inflamed Surface Area (PISA) will be calculated to quantify inflammatory burden. Oral health-related quality of life will be evaluated using the OSHIP-Perio questionnaire, a validated patient-reported outcome measure specific to periodontal conditions. The study will investigate the association between clinical periodontal findings, oral hygiene practices, and quality of life outcomes. The findings are expected to provide a comprehensive understanding of both clinical and patient-centered aspects of periodontal disease and contribute to improved individualized treatment approaches.

Being tested
Oral Health Assessment and OSHIP-Perio Questionnaire
Medical subject headings
Periodontal Diseases, Gingivitis, Periodontitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Oral Health Assessment and OSHIP-Perio QuestionnaireOther

    Participants will undergo a comprehensive periodontal clinical examination, including assessment of probing pocket depth (PPD), clinical attachment loss (CAL), bleeding on probing (BOP), and plaque and gingival indices. In addition, participants will complete the OSHIP-Perio questionnaire to evaluate the impact of periodontal status on oral health-related quality of life. No invasive or therapeutic intervention will be performed as part of this study.

Study groups in NCT07530978
Study groupRoleWhat they receive
PERIODONTITIS PATIENTSPatients with a diagnosis of periodontitis, irrespective of its stage and grade.This group will include individuals diagnosed with periodontitis, characterized by interdental clinical attachment loss (CAL) at ≥2 non-adjacent teeth and/or buccal/oral CAL ≥3 mm with pocketing >3 mm at ≥2 teeth, not attributable to non-periodontal causes. Participants will present with increased probing pocket depths (PPD ≥4 mm), bleeding on probing (BOP), and radiographic evidence of alveolar bone loss. The diagnosis and staging of periodontitis will be established according to the criteria defined by the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions.
Receives: Other: Oral Health Assessment and OSHIP-Perio Questionnaire
GINGIVITIS PATIENTSThis group will include individuals diagnosed with gingivitis, characterized by the presence of gingival inflammation without clinical attachment loss or radiographic evidence of alveolar bone loss. Participants will exhibit bleeding on probing (BOP) ≥10%, with probing pocket depths (PPD) ≤3 mm at all sites. The diagnosis of gingivitis will be established according to the criteria defined by the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions.
Receives: Other: Oral Health Assessment and OSHIP-Perio Questionnaire
periodontally healthy individualsThis group will consist of systemically healthy individuals presenting with clinically healthy periodontal tissues. Participants will have no clinical signs of gingival inflammation, no periodontal pocket formation, no clinical attachment loss (CAL), and no radiographic evidence of alveolar bone loss. All individuals in this group will demonstrate probing pocket depths (PPD) ≤3 mm at all sites and bleeding on probing (BOP) <10%, in accordance with the criteria defined by the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions.
Receives: Other: Oral Health Assessment and OSHIP-Perio Questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oral health-related quality of life (OSHIP-Perio score)

    The primary outcome is the Oral and Systemic Health Impact Profile for Periodontal Disease (OSHIP-Perio) total score obtained from a 21-item questionnaire assessing the impact of periodontal status on oral health-related quality of life.

    Measured: Baseline (single visit)

Secondary outcomes (5)
  1. Probing Pocket Depth (PPD)

    Probing pocket depth (PPD) will be measured in millimeters using a calibrated periodontal probe at six sites per tooth.

    Measured: Baseline (single visit)

  2. Periodontitis Stage (2017 Classification)

    Periodontitis stage will be determined according to the 2017 World Workshop Classification of Periodontal Diseases, based on clinical attachment loss, radiographic bone loss, and tooth loss.

    Measured: Baseline (single visit)

  3. Clinical Attachment Level (CAL)

    Clinical attachment level (CAL) will be measured in millimeters using a periodontal probe at six sites per tooth.

    Measured: Baseline (single visit)

  4. Bleeding on Probing (BOP)

    Bleeding on probing (BOP) will be assessed as the presence or absence of bleeding within 15 seconds after probing and recorded as percentage (%).

    Measured: Baseline (single visit)

  5. Periodontitis Grade (2017 Classification)

    Periodontitis grade will be determined according to the 2017 World Workshop Classification, based on rate of progression, risk factors, and clinical parameters.

    Measured: Baseline (single visit)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2026
  2. Study start15 Oct 2025
  3. Primary completion15 May 2026
  4. Study completion15 Jun 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
463 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07530978
Sponsor's protocol ID
BAIBU-SBF-RK-02
Status last verified
Sep 2026
First submitted
9 Apr 2026
Last updated
14 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be publicly shared to protect participant confidentiality. De-identified and aggregated data may be available from the corresponding author upon reasonable request.

Questions about this trial

What is this clinical trial studying?

An observational study of Periodontal Diseases and Gingivitis, run by Abant Izzet Baysal University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oral health-related quality of life (OSHIP-Perio score) (time frame: Baseline (single visit)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in